Chi Sheng Pharma & Biotech Financial Health
How is Chi Sheng Pharma & Biotech's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 4111's short term assets (NT$699.8M) exceed its short term liabilities (NT$509.9M).
Long Term Liabilities: 4111's short term assets (NT$699.8M) exceed its long term liabilities (NT$102.6M).
Debt to Equity History and Analysis
Debt Level: 4111 has more cash than its total debt.
Reducing Debt: 4111's debt to equity ratio has increased from 2% to 11.8% over the past 5 years.
Debt Coverage: 4111's debt is well covered by operating cash flow (151.3%).
Interest Coverage: 4111's interest payments on its debt are well covered by EBIT (217.4x coverage).